American Heart Association
My Top Clinical-Practice Changing Papers this Year
Primary Care
Grand Ballroom 6
Sep 7th , 08:00 AM - 08:45 AM
08 : 00 AM
Antihypertensive Medication Timing and Cardiovascular Events and Death The BedMed Randomized Clinical Trial. irzepatide for the treatment of OSA and obesity
Voora Raven
Final Pr. ID: -
Authors: Voora Raven
08 : 10 AM
The Global Risk Consortium. Global effect of CV risk factors on lifetime estimates 2Saxena M, et al. Lorundrostat in participants with uncontrolled hypertension and treatment-resistant hypertension
Weir Matthew
Final Pr. ID: -
Authors: Weir Matthew
08 : 20 AM
BPROAD Research Group. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease. Nephrol Dial Transplant
Townsend Raymond
Final Pr. ID: -
Authors: Townsend Raymond
08 : 00 AM
Antihypertensive Medication Timing and Cardiovascular Events and Death The BedMed Randomized Clinical Trial. irzepatide for the treatment of OSA and obesity
Voora Raven
Final Pr. ID: -
Authors: Voora Raven
08 : 20 AM
BPROAD Research Group. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease. Nephrol Dial Transplant
Townsend Raymond
Final Pr. ID: -
Authors: Townsend Raymond
08 : 10 AM
The Global Risk Consortium. Global effect of CV risk factors on lifetime estimates 2Saxena M, et al. Lorundrostat in participants with uncontrolled hypertension and treatment-resistant hypertension
Weir Matthew
Final Pr. ID: -
Authors: Weir Matthew